KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Other Working Capital Changes (2016 - 2026)

Amgen has reported Other Working Capital Changes over the past 18 years, most recently at -$8.0 million for Q1 2026.

  • For Q1 2026, Other Working Capital Changes fell 103.98% year-over-year to -$8.0 million; the TTM value through Mar 2026 reached $1.1 billion, up 38.48%, while the annual FY2025 figure was $1.3 billion, 94.33% up from the prior year.
  • Other Working Capital Changes for Q1 2026 was -$8.0 million at Amgen, down from $577.0 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $577.0 million in Q4 2025 and troughed at -$241.0 million in Q2 2022.
  • A 5-year average of $130.4 million and a median of $139.0 million in 2023 define the central range for Other Working Capital Changes.
  • Biggest five-year swings in Other Working Capital Changes: plummeted 315.18% in 2022 and later soared 4021.43% in 2025.
  • Year by year, Other Working Capital Changes stood at -$92.0 million in 2022, then soared by 352.17% to $232.0 million in 2023, then tumbled by 93.97% to $14.0 million in 2024, then soared by 4021.43% to $577.0 million in 2025, then plummeted by 101.39% to -$8.0 million in 2026.
  • Business Quant data shows Other Working Capital Changes for AMGN at -$8.0 million in Q1 2026, $577.0 million in Q4 2025, and $283.0 million in Q3 2025.